The reactions of (Cl)Ir(PR& (R = Me, Et) with potassium oxapentadienide, potassium I-methyl-5-oxapentadienide, and potassium 2,4-dimethyl-Boxapentadienide have been investigated. Treatment of (Cl)Ir(PMe& with potassium oxapentadienide initially produces ((1,2,5-+S-oxapentadienyl)Ir(PMe3)3 (l), which rapidly rearranges to ((1,2,3-q)-5-oxapentadienyl)-Ir(PMe3)s (2a). When refluxed in tetrahydrofuran, 2a undergoes metal-centered activation of the aldehydic C-H bond (C4-H) to produce the iridacyclopentenone complex fac-CH2-CH=CH-C(0)-Ir(PMe3)3(H) (3). Treatment of (Cl)Ir(PEt& with potassium oxa-I 1 pentadienide yields the iridapyran complex mer-CH=CH-CH=CH-O-Ii(PEt3)3(H) (4) via activation of a C-H bond on the C-terminus (Cl) of an O-bound 7'-oxapentadienyl ligand.Upon stirring in tetrahydrofuran solution, 4 gradually converts to the iridacyclopentenone complex fac-CH2-CH=CH-C (0)-Ir (PEt3)3( H) (5). Treatment of (Cl) Ir (PMe3)3 with potassium 4-methyl-5-oxapentadienide produces ((1,2,5-q)-4-methyl-5-oxapentadienyl)Ir(PMe3)3 (6). However, upon refluxing in tetrahydrofuran, this species undergoes C-H bond activation at C2 of the 4-methyl-5-oxapentadienyl ligand, generating the iridaoxacyclopentene derivative mer-compounds and anionic heteropentadienide reagents as our building blocks.Our initial studies have focused on electron-rich heteropentadienyl-iridium (1)-phosphine complexes because these species have a propensity to undergo C-H bond activation, generating novel metallacyclic products.4 In this paper, we describe the reactions of (Cl)Ir(PR& (R = Me and Et) precursors with potassium oxapentadienide, potassium 4-methyl-5-oxapentadienide, and potassium 2 , 4 dimethyl-5-oxapentadienide, which yield (oxapentadienyl)Ir(PR& complexes as kinetic products. However, these initially-formed species undergo intramolecular, iridium-centered C-H bond activation to produce fiveand six-membered iridacycles as the thermodynamic products. The site of C-H bond activation is strongly influenced by the location of the methyl substituents on the oxapentadienyl backbone; hence, these reactions can be directed toward a particular metallacyclic product by choosing the appropriate oxapentadienide reagent.Bleeke et al. Results and DiscussionA. Oxapemtadienide Reagents. While a variety of synthetic approaches to (oxapentadieny1)metal complexes have been explored over the years,5 anionic oxapentadienide reagents have not previously been employed to introduce oxapentadienyl ligands onto transition metal centers. These reagents promise to provide a new general route to (oxapentadieny1)metal complexes via nucleophilic displacement of anionic ligands from metal precursors.Potassium oxapentadienide, first reported by Heiazwolf and Kloosterzie16 in 1967, can be readily synthesized by deprotonating crotonaldehyde with potassium amide in liquid ammonia. Analogous treatment of 3-penten-2-one and mesityl oxide with potassium amide in liquid ammonia generates potassium 4-methyl-5-oxapentadienide and potassium 2,4-dimethyl-5-oxapentadienide, respective...
The first single‐crystal studies of three bis‐transoid Cu–hydroxamate salts, bis(3‐methoxy‐4,N‐dimethylbenzohydroxamato‐O,O′)copper(II), [Cu(C10H12NO3)2], bis(4‐chloro‐N‐methylbenzohydroxamato‐O,O′)copper(II), [Cu(C8H7ClNO2)2], bis(N‐methyl‐3,5‐dinitrobenzohydroxamato‐O,O′)copper(II)–chloroform (1/2), [Cu(C8H6N3O6)2]·2CHCl3, are presented. The Cu atom in each of the title compounds sits at a center of inversion and displays a nearly square‐planar geometry with the hydroxamate‐O atoms connected to it in a syn configuration. The N atoms are in a transoid configuration. Each five‐membered Cu–hydroxamate ring is planar, thus providing evidence that a planar N atom is present in each ring. The phenyl groups are twisted with respect to the hydroxamate group by ∼40–54°. The angular strain of the sp2 carbonyl oxygen is significant (∼10° from ideal).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.